The earliest date that a generic Abilify drug could become available is April 2015, when the patent for Abilify expires. Until there is an approved generic version of the medication, you should not purchase any products sold as "generic Abilify." These drugs may be fake, substandard, and potentially dangerous.
Abilify® (aripiprazole) is a prescription medication that has been licensed to treat several conditions. These Abilify uses can include the treatment of:
- Irritability associated with autistic disorder.
Abilify is manufactured by Otsuka America Pharmaceutical, Inc. and Bristol-Myers Squibb Company. The medicine is currently protected by a patent that prevents any generic Abilify from being manufactured. Yet, if you search the Internet for "generic Abilify," you may find a number of companies selling it. The fact is that these medicines may be fake, substandard, and potentially dangerous.
You should not buy any generic Abilify until there is an approved version available.
The patent for Abilify currently expires in April 2015. This is the earliest possible date that a generic version of Abilify could become available. However, there are other circumstances that could come up to extend the exclusivity period of Abilify beyond 2015. These circumstances could include things such as lawsuits or other patents for specific Abilify uses.
Once Abilify goes off patent, there may be several companies that will begin manufacturing a generic Abilify drug.